Analyst Ratings for Intra-Cellular Therapies (ITCI)

ITCI Rating Summary

ITCI Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ITCI
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $54.38 (+46.6%) * Over Last 12-Mos
Rating Score: 9.4 / 10   Percentile Rank: 90%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/15/2020 BofA Securities N/A New Coverage Buy
(N/A)
N/A
(N/A)
25.27
(37.10)
46.81% Details
12/10/2020 Goldman Sachs
» Updated 3/1/2021
Graig Suvannavejh, New Coverage Buy
(N/A)
50.00
(38.00)
25.80
(37.10)
43.8% Details
Like ITCI Ratings? Also take a look at RPRX, ADCT, FGEN

ITCI Ratings News